Alice W. Lee

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Expanding Our Understanding of Ovarian Cancer Risk: The Role of Incomplete Pregnancies”.

Expanding Our Understanding of Ovarian Cancer Risk: The Role of Incomplete Pregnancies

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa099

N/A

1.1DataRank · unranked

38 citations

Stacey Rosenzweig, Ashley Wiensch, the Australian Ovarian Cancer Study Group, Susan J. Ramus, Usha Menon +41 more

Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.10.088

N/A

0.516DataRank · unranked

14 citations

Rachel Palmieri Weber, Penelope M. Webb, Susan J. Jordan, Aruna Muthukumar, Jenny Chang‐Claude +25 more

Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival

Gynecologic Oncology(2020)10.1016/j.ygyno.2020.06.481

N/A

0.510DataRank · unranked

29 citations

Siri Peterson, Alice W. Lee, Bhramar Mukherjee, Kelly M. Bakulski, Aliya Alimujiang +46 more

Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.10.018

N/A

0.165DataRank · unranked

2 citations

Penelope M. Webb, Anna deFazio, Sián Fereday, Alice W. Lee, David D.L. Bowtell +25 more

Reproductive Factors Do Not Influence Survival with Ovarian Cancer

Cancer Epidemiology Biomarkers & Prevention(2022)10.1158/1055-9965.epi-21-1091

N/A

0DataRank · unranked

3 citations

Aliya Alimujiang, Andrew Berchuck, Hoda Anton-Culver, Joellen M. Schildkraut, Elisa V. Bandera +21 more

Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad011

N/A

0DataRank · unranked

26 citations

Maria M. Brooks, Sarah Irvin, Susan J. Jordan, Katja K.H. Aben, Hoda Anton‐Culver +58 more

A framework for assessing interactions for risk stratification models: the example of ovarian cancer

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad137

N/A

0DataRank · unranked

3 citations

Alice W. Lee, Karen McLean, Hoda Anton‐Culver, Elisa V. Bandera, Michael E. Carney +26 more

Pre-diagnosis tea and coffee consumption and survival after a diagnosis of ovarian cancer: results from the Ovarian Cancer Association Consortium

British Journal of Cancer(2024)10.1038/s41416-024-02792-7

N/A

0DataRank · unranked

6 citations

Torukiri I Ibiebele, Elisa V. Bandera, Daniel W. Cramer, Jennifer Anne Doherty, Graham G. Giles +21 more

Estrogen Plus Progestin Hormone Therapy and Ovarian Cancer

Epidemiology(2020)10.1097/ede.0000000000001175

N/A

0DataRank · unranked

34 citations

Anna H. Wu, Ashley Wiensch, Bhramar Mukherjee, Kathryn L. Terry, Holly R. Harris +24 more

Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of Progestins

Cancer Epidemiology Biomarkers & Prevention(2021)10.1158/1055-9965.epi-20-1355

N/A

0DataRank · unranked

21 citations

Alice W. Lee, Anna H. Wu, Andrew Berchuck, Kathleen R. Cho, Daniel W. Cramer +16 more

Effects of risk factors for ovarian cancer in women with and without endometriosis

Fertility and Sterility(2022)10.1016/j.fertnstert.2022.07.019

N/A

0DataRank · unranked

18 citations

Aruna Muthukumar, Britton Trabert, Penelope M. Webb, Susan J. Jordan, Kathryn L. Terry +19 more